Article Details

Metastatic Castration-Sensitive Prostate Cancer Market to Reach Upto USD 5.5 billion by 2032

Retrieved on: 2022-06-20 16:18:51

Tags for this article:

Click the tags to see associated articles and topics

Metastatic Castration-Sensitive Prostate Cancer Market to Reach Upto USD 5.5 billion by 2032. View article details on hiswai:

Excerpt

... Bristol-Myers Squibb, Novartis Pharmaceuticals, Ferring Pharmaceuticals, Genentech, Exelixis, AstraZeneca, and others are reported to bring a ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up